Authors:
JOZAN S
COURTADE M
MATHIEUBOUE A
LOCHON I
BUGAT R
Citation: S. Jozan et al., CYTOTOXIC EFFECT OF INTERFERON-ALPHA-2A IN COMBINATION WITH ALL-TRANS-RETINOIC ACID OR CISPLATIN IN HUMAN OVARIAN-CARCINOMA CELL-LINES, Anti-cancer drugs, 9(3), 1998, pp. 229-238
Authors:
GUICHARD S
CHATELUT E
LOCHON I
BUGAT R
MAHJOUBI M
CANAL P
Citation: S. Guichard et al., COMPARISON OF THE PHARMACOKINETICS AND EFFICACY OF IRINOTECAN AFTER ADMINISTRATION BY THE INTRAVENOUS VERSUS INTRAPERITONEAL ROUTE IN MICE, Cancer chemotherapy and pharmacology, 42(2), 1998, pp. 165-170
Authors:
CALIARO MJ
VITAUX P
LAFON C
LOCHON I
NEHME A
VALETTE A
CANAL P
BUGAT R
JOZAN S
Citation: Mj. Caliaro et al., MULTIFACTORIAL MECHANISM FOR THE POTENTIATION OF CISPLATIN (CDDP) CYTOTOXICITY BY ALL-TRANS-RETINOIC ACID (ATRA) IN HUMAN OVARIAN-CARCINOMACELL-LINES, British Journal of Cancer, 75(3), 1997, pp. 333-340
Authors:
LAVIT M
CHEVREAU C
CHATELUT E
DEFENIN V
LOCHON I
HOUIN G
BUGAT R
CANAL P
Citation: M. Lavit et al., RELATIONSHIPS BETWEEN HEMATOLOGICAL TOXIC ITY AND TOTAL AND FREE ETOPOSIDE PLASMATIC LEVELS WITH DAILY ORAL ETOPOSIDE ADMINISTRATION, Bulletin du cancer, 82(8), 1995, pp. 660-664